RNA methylation in inflammatory bowel disease (Cancer Sci, 2023)

RNA methylation in inflammatory bowel disease (Cancer Sci, 2023)

 

In the collaboration with Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Japan (Professors Eguchi and Doki), Dr. Ozato has focused on RNA methylation in inflammatory bowel disease (IBD), and emerged the significance in the process of inflammation, occurrence, and development of cancer. The information is expected to provide the potential applications of RNA modifications in the diagnosis and treatment of these diseases.